Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
CORT Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/cort/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

CORCEPT THERAPEUTICS INC (CORT) Insider Trading

30 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 30 sales worth $68.2M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
James N. WilsonDirector0$05$5.08MOct 16, 2026
Sean MaduckSee Remarks0$08$14.7MOct 5, 2026
Joseph Douglas LyonSee Remarks0$04$2.47MOct 5, 2026
Roberto Wandenkolk VieiraPresident0$03$7.46MOct 5, 2026
Kimberly ParkDirector0$01$3.27MAug 28, 2026
David L. MahoneyDirector0$02$13.9MAug 20, 2026
Gary Charles RobbChief Business Officer0$01$1.16MAug 18, 2026
William GuyerChief Development Officer0$03$4.13MAug 12, 2026
Atabak MokariCFO0$03$15.9MAug 3, 2026

All trades

CORT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 16Oct 15James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000114.81$1.15M−0.9%Form 4 ↗
Oct 5Oct 2Sean MaduckSee RemarksSee Remarks▼ SELL10b5-124,587116.28$2.86M−71%Form 4 ↗
Oct 5Oct 2Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-19,190116.13$1.07M−62%Form 4 ↗
Oct 5Oct 2Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-18,333116.10$967K−68%Form 4 ↗
Oct 5Oct 1Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-1810115.40$93K−13%Form 4 ↗
Oct 5Oct 1Sean MaduckSee RemarksSee Remarks▼ SELL10b5-1413115.54$48K−4.0%Form 4 ↗
Sep 18Sep 16Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-1296100.82$30K−7.0%Form 4 ↗
Sep 16Sep 14Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-110,000113.49$1.13M−64%Form 4 ↗
Sep 16Sep 15James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000110.69$1.11M−0.9%Form 4 ↗
Sep 3Sep 2Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-158,333110.76$6.46M−91%Form 4 ↗
Sep 3Sep 1Sean MaduckSee RemarksSee Remarks▼ SELL10b5-125,000114.43$2.86M−72%Form 4 ↗
Aug 28Aug 26Kimberly ParkDirectorDirector▼ SELL26,685122.55$3.27MAll soldForm 4 ↗
Aug 27Aug 25Sean MaduckSee RemarksSee Remarks▼ SELL10b5-130,955125.58$3.89M−76%Form 4 ↗
Aug 20Aug 18David L. MahoneyDirectorDirector (ind.)▼ SELL10b5-1103,606118.25$12.3M−8.4%Form 4 ↗
Aug 18Aug 17Gary Charles RobbChief Business OfficerChief Business Officer (ind.)▼ SELL10,000116.26$1.16M−20%Form 4 ↗
Aug 18Aug 14James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000111.43$1.11M−0.9%Form 4 ↗
Aug 18Aug 14Sean MaduckSee RemarksSee Remarks▼ SELL10b5-13,664114.49$419K−27%Form 4 ↗
Aug 12Aug 10William GuyerChief Development OfficerChief Development Officer▼ SELL10b5-116,300113.43$1.85M−80%Form 4 ↗
Aug 12Aug 10Sean MaduckSee RemarksSee Remarks▼ SELL10b5-11,031114.52$118K−9.6%Form 4 ↗
Aug 6Aug 4William GuyerChief Development OfficerChief Development Officer▼ SELL10b5-13,700113.12$419K−48%Form 4 ↗
Aug 5Aug 3Sean MaduckSee RemarksSee Remarks▼ SELL10b5-120,305114.70$2.33M−68%Form 4 ↗
Aug 5Aug 3Joseph Douglas LyonSee RemarksSee Remarks▼ SELL1,540114.16$176K−22%Form 4 ↗
Aug 3Jul 30Atabak MokariCFOCFO▼ SELL10b5-180,000114.71$9.18M−68%Form 4 ↗
Jul 17Jul 15Atabak MokariCFOCFO▼ SELL10b5-140,00087.71$3.51M−71%Form 4 ↗
Jul 17Jul 15James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,00088.30$883K−0.9%Form 4 ↗
Jul 8Jul 7William GuyerChief Development OfficerChief Development Officer▼ SELL10b5-120,00093.13$1.86M−83%Form 4 ↗
Jul 6Jul 1Sean MaduckSee RemarksSee Remarks▼ SELL10b5-125,00088.35$2.21M−72%Form 4 ↗
Jun 18Jun 17David L. MahoneyDirectorDirector (ind.)▼ SELL20,00084.53$1.69M−43%Form 4 ↗
Jun 18Jun 16James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,00083.20$832K−0.9%Form 4 ↗
Jun 17Jun 15Atabak MokariCFOCFO▼ SELL10b5-140,00081.15$3.25M−71%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings